PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have one or more addictions
- People whose results on a substance use questionnaire (called the ASSIST) reach a certain level — a score of 11 or higher for alcohol, or 4 or higher for other substances
- People who have been assessed and diagnosed with PTSD (post-traumatic stress disorder) and/or Complex PTSD, using a specific assessment tool called the ITQ scale
- People who can understand, read, and write in French
- People who have freely given their informed consent to take part
- People who are covered by a health insurance plan
Who may not be able to join:
- People who have taken part in another clinical trial involving a drug or medical device (or a Category 1 research study) in the 3 months before joining this trial
- People who are under a legal protection measure such as court safeguard or state guardianship
- People who have a psychotic disorder
- People with severe cognitive impairment, as measured by a score below 10 on a standard cognitive test called the MoCA (confirm with trial site)
- People who are currently experiencing a manic or hypomanic episode
- People who are currently experiencing a major depressive episode
- Women who are pregnant, in labour, or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laure Thebault, CHU de Nimes
Phone: 06.80.13.54.39
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of a shortened 12-week ECCCLORE program for patients with addiction and trauma issues; Dropout rate of a shortened 12-week ECCCLORE program for patients with addiction and trauma issues.; Acceptability of the home practice section of the ECCCLORE program
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.